Background Several countries affected by the COVID-19 pandemic have reported a substantial
drop in the number of patients attending the emergency department with acute coronary …

Background Statin therapy has been shown to reduce major vascular events and vascular
mortality in a wide range of individuals, but there is uncertainty about its efficacy and safety …

Background There are concerns that the COVID-19 pandemic has had a negative effect on
cancer care but there is little direct evidence to quantify any effect. This study aims to …

Background REGEN-COV is a combination of 2 monoclonal antibodies (casirivimab and
imdevimab) that bind to two different sites on the receptor binding domain of the SARS-CoV-2 …

Background Statin therapy is effective for the prevention of atherosclerotic cardiovascular
disease and is widely prescribed, but there are persisting concerns that statin therapy might …

Background Treatment of COVID-19 patients with plasma containing anti-SARS-CoV-2
antibodies may have a beneficial effect on clinical outcomes. We aimed to evaluate the safety …

Background Gastroprotectant drugs are used for the prevention and treatment of peptic ulcer
disease and might reduce its associated complications, but reliable estimates of the effects …

Background Angiotensin receptor blockers (ARBs) and β blockers are widely used in the
treatment of Marfan syndrome to try to reduce the rate of progressive aortic root enlargement …

Background Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-thrombotic
properties. We aimed to evaluate the efficacy and safety of aspirin in patients …

Background Previous meta-analyses of summary data from randomised controlled trials have
shown that statin therapy increases the risk of diabetes, but less is known about the size or …